While the FDA is in favor of innovation and advancing public … She holds a BS in public health, and MPH in practice and policy from the University of Maryland. They require pharmaceuticals to connect their database to a central verification hub. The promise of cell and gene therapies is being delivered to patients; rare diseases, previously believed to be incurable, are on the precipice of real cures. Nine pharma trends for 2020. Filing prescriptions will be more straightforward because those issued in one country can get filed in another state. Medical data is going digital with the help of AI. This explains why 60% of pharma companies are already updating their talent sourcing, with another 27% considering changes. View in article, Deloitte, “Opportunities in China’s pharmaceutical market,” 2011. Our Team is always trying to produce Quality Content for Our Readers. Even though it seems like a lot has changed around us in the last few months, our analysis of investor call transcripts and a survey conducted during the pandemic suggest that many of these statements are still true. See something interesting? Merck cyberattack’s $1.3 billion question: Was it an act of war? View in article, Ryan Myers, Margaret Anderson, and Casey Korba, Striving to become more patient-centric in life sciences, Deloitte Insights, January 30, 2020. This model can require a dedicated team to assess, deploy, and evolve a portfolio of partnerships. In response to this, some national pharmaceutical regulatory bodies have made product serialization a requirement. Despite this urgency, bets should be selective and strategic; companies should prepare for risk but not let it hold them back. Your email address will not be published. Emerging ecosystems may accelerate this trend; it is critical for pharma companies to arm themselves with data so that they can continue to have a seat at the table. to receive more business insights, analysis, and perspectives from Deloitte Insights, Telecommunications, Media & Entertainment, Deloitte’s vision of the future of health, Covid-19 pandemic could forever change biopharma, Big pharma sports smallest late-stage pipeline for a decade. Rather than focusing on geography, shifting the mission of these individuals to disrupt the status quo from within can be a strong recruitment driver. Survey responses indicate that the focus of digital investments for biopharma companies will remain on gaining insights into the execution of business strategies—inclusive of understanding and adapting to changes in customer behavior (28%), improving the efficiency of the R&D process (25%), and fast-tracking products to market (15%) (figure 3). Global Pharmaceuticals Industry Analysis and Trends 2023 Global pharmaceutical market is expected to grow in the upcoming years despite recent slowdown in … From a talent perspective, conquering the next frontier will likely require new talent and organizational structures to effectively play in the world of today and tomorrow simultaneously. When asked about the top issues that will have the greatest impact on their company in the next year, pharma company leaders ranked the following challenges as their biggest concerns: Changes in consumer attitudes and behavior: Consumers are changing their attitudes and behaviors in numerous ways—from increased use of technology and willingness to share data, to their interest in using tools to make decisions about prescriptions and care.5 Survey responses aligned with Deloitte’s vision of the future of health centered on the consumer—80% of respondents chose changes in consumer attitudes and behavior as an issue that will have the greatest impact on their company (figure 1). Copy a customized link that shows your highlighted text. 2020 will also see big data and AI technology continue to take center stage in the pharmaceutical industry. Other pharmacies are becoming one-stop shops for their customers. Leaders of pharma companies are in the midst of unprecedented change. By Ed Silverman @Pharmalot. Now, through real-world evidence, health systems and health plans may know even more about how well drugs work in patients than pharma companies do. Some countries have started a ‘continuity of care along with borders’ initiative. Additionally, globally, social unrest around racism issues is increasingly calling on leaders to develop, implement, and sustain new initiatives. Pharma leaders are particularly attuned to managing risks, sometimes at the expense of innovating the model to address market evolution. Most important is selecting the right technologies and integrating them.”, “It is the time of digital presence. View in article, David Voreacos, Katherine Chiglinsky, and Riley Griffin, “Merck cyberattack’s $1.3 billion question: Was it an act of war?,” Bloomberg, December 3, 2019. It can enable leaders to cultivate a playbook of informed bets they can place in response to ongoing market evolution, driving down the potential execution risk to the core business while enabling the margins to find new opportunities to perform. Some trends are due to the COVID-19 pandemic. View in article, Greg Reh and Mike Standing, Survey finds biopharma companies lag in digital transformation: It is time for a sea change in strategy, Deloitte Insights, October 4, 2018. Findings from a new survey and analysis of investor calls in the first half of 2020, Change in consumer behavior prompting a change in strategic thinking, Strategic priorities include R&D, establishing presence in global markets, and transformation of functions using digital and information technologies, Digital maturity: Investments rise, but many aren’t there yet, The future of health for biopharma companies in the decade ahead, “Considering the pandemic, the world is witnessing, strategies for drug development is our focus. Customers are getting more interested in beauty and wellness products, while some pharmacies are trying to bridge the gap between nutrition and medicine. This study would not have been possible without our survey participants. Though the concept of good manufacturing practises (GMP) was implemented for chemical production in the early 1990s, the rules and regulations for our industry are in constant evolution. One way that companies are addressing this strategic priority is through explicit patient-centric strategies. 1.Cost of Drugs and Raw materials That means. More than half (52%) selected transforming business functions. Alok Ranjan and Shruti Panda led the text analysis efforts and Madhushree Wagh interpreted the findings. This Information is very Authentic and Useful for the People. Many new online pharmacy services have entered the industry. They need an organization that will thrive in today’s market while simultaneously preparing for the next market disruption.Most pharma companies have business models that are focused on certain geographies and customers. Most pharmaceutical companies will focus on online medicine distribution services for this year. It has made it easier for patients with dietary illnesses to get proper nutrition. We also analyzed investor call transcripts from 38 of the largest (by revenue) biopharma companies for Q4 2019 and Q1 2020. An emerging trend of the pharmaceutical industry in 2020 is the high demand for multivitamins. While COVID-19 has fueled investments in digital R&D and customer engagement, it has also accelerated the transformation of health care delivery. The switch to online operations is a direct result of social distancing measures. Both the survey and the second round of investor statements were sourced during March and April 2020, at the peak of the COVID-19 pandemic. Discover Deloitte and learn more about our people and culture. Another trend is the rise of online pharmacies. Pharma companies face a range of policy and regulatory issues—activity that affects the pace at which drugs come to market, supply chain and safety, tax, and pricing polices limiting payment rates. While this was true even before COVID-19, the pandemic and the ensuing economic downturn have brought about a sea change in the way organizations look at the road ahead. Evolving technologies, including blockchain, can help facilitate data interoperability, so that patient data can be more easily used for holistic and longitudinal analysis of health outcomes. It also lays out areas where support that the government and regulatory agencies need to provide to bring the industry back on Pharmaceutical companies may deal in generic or brand medications and medical devices. Companies are also taking a broadminded approach to health. Pols, lawmakers are putting the industry in their crosshairs ahead of the 2016 election. Companies believe that transforming functions using digital technologies will be of high strategic priority in the next five years. Emerging Trends of Pharmaceutical Industry in 2020. Although executives did not prioritize talent issues, it is a given that a talent strategy will be needed to fully leverage new technologies and be a digitally enabled company, either through recruitment or through partnerships. Tops Health Info is Trying to Give the Best Information to the people. These innovation hubs can test new roles, technologies, policies, and strategies in an environment where failure is likely no worse than the status quo. Here Are Some Simple Steps To Help You, 5 Ways to Cope with Lower Back Pain After a Car Accident, What to Eat When You are Gluten Intolerant. He works with corporate leadership to identify market opportunities, build sustainable capabilities, and transform business and organizational models for growth. While many biopharma companies are experimenting with digital, most have not yet made consistent, sustained, and bold moves to take advantage of new capabilities. While these challenges continue to disrupt the industry, the pandemic has also propelled multiple partnerships to develop a COVID-19 vaccine. Capsul reported a rapid expansion in customers by using this measure. It is comprised of businesses producing and developing new drugs and generic drugs, and also over the counter pharmaceuticals. Bushra Naaz is a manager with the Deloitte Center for Health Solutions. People began to focus more on their immunity, and dietary requirements as concerns over contracting disease and viruses began to turn into panic. As we wrote in an article on patient-centricity earlier this year, “companies should not only embrace [a patient-centric] approach, but prepare to participate in an emerging ecosystem where philanthropies dedicated to particular diseases, patient advocacy groups, health plans, health systems and physicians, regulators, competitors, and technology and wellness companies are all better connected so that the patient is at the center.”6, —EVP/VP business/corporate development, biopharma company, Cyber and advances in technology: The next most common issues cited were cybersecurity threats (70%) and advances in technology (68%). As expected, the word “vaccine” gained prominence between the two periods. View in article, Deloitte, Deal breaker: Cyber risk in life sciences M&A, 2018. Due to social distance measures, fewer people are going to pharmacies. Biopharma companies and regulators are exploring opportunities to work together to streamline the drug development and review processes, which could lead to the emergence of new business models. Additionally, here’s what our analysis found: The data comes from two different sources. Please see www.deloitte.com/about to learn more about our global network of member firms. Consumers will continue to shift their spending to personalized mobile apps in the future. Other new services introduced this year include GoApotik, which has partnered with an eCommerce retailer for distribution. Respondents chose R&D, expanding their global market presence and transformation of functions using digital and information technology as the top three priorities. Increased investment in and deployment of home-based health technologies are creating new opportunities for biopharma companies to create value. We need to grow our reachability to a larger extent.”, “Need to adapt to market changes with respect to customer needs.”, “Our major concerns would include security issues because of intervention of technologies like IoT, managing the epidemic going on right now and finding a cure, and working on customized treatments based on previous data available.”, “Our top strategic priority would be to start more and more R&D initiatives globally so we have a good hold in each market for research.”, “Overall productivity by digital partnering and advancements in technology is key. Their interactive mySugrApp engages patients with interactive dialog and modern engagement. Global market presence continues to be a top focus area for companies, with close to 60% of respondents rating it as a high priority. Our aim to help those people who are searching for the Right info. The words “China” and “rare” shrunk from their relatively prominent position in Q4 2019. According to Amato and Detwiler, there are several emerging trends influencing hiring patterns in the industry. Comprehensive audit, advisory, consulting, and tax capabilities can deliver value at every step, from insight to strategy to action. M&A, leveraging digital (including AI) for transforming business, refocusing on therapeutic area strategy, and balancing new opportunity with risk are also being considered important in the next five years. A 2019 Deloitte study points out that while biopharma companies made significant R&D investments to innovate in the last 10 years, the returns declined significantly during that same period—from 10.1% to 1.8%. Amazon’s new online pharmacy company Amazon Pharmacy is fully operational and set to dominate the market. Here are some of the top talent trends in the pharma industry today: Flexibility In our previous research, global executives, business leaders, and analysts of biopharma companies said they were somewhere along the half-way mark in terms of achieving digital maturity and adoption of flexible leadership and learning models.12. Tracking serialization will show the drug’s current and past locations, and tracing ill show who came into contact with it. There will be a focus on making the drug manufacturing and distributing procedures efficient by integrating technology. Tablets specially formulated to fulfill specific nutritional requirements like elevit with iodine will continue to remain in-demand, as prescribed for pregnant women. Find out more at https://www2.deloitte.com/us/en/industries/life-sciences-and-health-care.html. The direct effects of the pandemic include suspended trials for drugs other than those for COVID-19, delayed product launches, inability of the sales force to carry out in-person visits, supply chain disruption, and overall delays in drug commercialization. Body SensorsFollowing the trend of Artificial Intelligence (AI), there is stepping in the trend of body … History. We will only see more use of AI in the pharmaceutical industry in the future. View in article, Through text analysis, we do not have insight into strategic execution issues since these typically are not the focus of analyst calls or top of mind in our unstructured comments but are equally important for success. While COVID-19 has forced biopharma companies to focus on immediate priorities, findings from a new survey indicate strategizing for tomorrow may be key to thrive in the future. Survey respondents included individuals in the following roles: chief executive officer (CEO), chief operating officer (COO), chief commercial officer (CCO), and EVPs/VPs business/corporate development of 60 biopharma companies (~60% companies with revenue more than US$1 billion and less than US$5 billion). Kroger is now offering patient vaccinations and screening at their pharmacies. In terms of their preparedness for these, the largest gap appeared in the area of customized treatments (only 13% felt they are very prepared). Companies are required to collect, store, and transfer data between different supply chain partners. © 2021. A recent report found that the pandemic has decreased the number of novel late-stage assets, which already were declining in the last four years.4 The report also shows merger and acquisition activity to be slower in 2020 than other years. This would leave us with in the region of 260 M&A deals executed through 2020 — one for every working day of the year. The key is to build an organization that can thrive in today’s market, while being ever ready for the next market turn. Patients will also interact more with pharmaceutical companies to focus on selling ‘experiences’ rather than products. Her recent research has focused on the future of health, drug pricing policies, and digital technology innovation. Data-driven approaches have the potential to create value across manufacturing, the supply chain, and the entire health care ecosystem.”1. Required fields are marked *, When it comes to swimming, the guidelines are the same as elsewhere: All swimmers must follow proper hygiene. Your email address will not be published. The pharmaceutical industry is one of Canada's key creative sectors. Simply select text and choose how to share it: Biopharma leaders prioritize R&D, technological transformation, and global market presence Companies could be well served to take advantage of this momentum to incorporate digital technologies into the patient experience, either in clinical trials or via digital medicines and therapeutics. Conclusion. Bushra holds a postgraduate business management diploma in international business from the Symbiosis Institute of Management Studies, Pune, and a bachelor’s degree in science from Ambedkar University, Agra. December 30, 2020. Solid Dose Pharmaceuticals Remain Strong. To drive growth, pharmaceutical industry will require a comprehensive shift in its business model and operations that can help in providing a better experience to customers, improving Some companies are beginning to use AI technology to automate workflow and production. Technologies such as sensors, monitors, at-home diagnostics, and digital therapeutics create massive amounts of data that can be used for improving the clinical trial process and therapeutics, as well as for labeling and targeting products to patient populations who can benefit from them the most. But while this work on therapeutics and a vaccine is on companies’ to-do list, some of them said that the pandemic has compelled them to focus on immediate and existing priorities (e.g., R&D, digital transformation, cyber) across therapeutic areas and functions. In addition, the US Food and Drug Administration (FDA) has, in partnership with the biopharma industry, introduced many regulatory changes around approving COVID-19-related treatment research. The current COVID-19 crisis will bring more challenges into the picture and is likely to impact our goals in many areas.”, “We are not prepared for meeting rising customer expectations. Some pharmaceutical companies introduced apps to remind users to refill their medications. View in article, Edwin Elmhirst and Lisa Urquhart, “Big pharma sports smallest late-stage pipeline for a decade,” Evaluate Vantage, June 17, 2020. Tops Health Info is the Blog about Health & Fitness Related Topics. ... in Accenture’s pharmaceutical strategy practice prior to joining IQVIA. A lot of pharmacies are also looking to expand their services. Through her research, she helps inform Deloitte’s health care and life sciences clients about emerging trends, challenges, and opportunities. In our survey, we posed several open-ended questions to our respondents, to understand their strategic priorities in their own words. For example, many multinational players who formerly regarded China primarily as a source of raw materials or research are now viewing China as a key market. To change the narrative, they may need to commit to a cultural shift that incentivizes deliberate risk-taking rather than maintaining the status quo. Social login not available on Microsoft Edge browser at this time. Companies are using AI to identify suitable drugs for medical conditions while cutting down costs and time. Pharma industry is no exception. The survey was conducted in March and April of 2020. Others who have previously entered the market through joint ventures with Chinese companies and research institutes are now ready to ramp up their growth in China through drug licensing and acquisitions. —Primarily middle-sized companies in terms of revenue growing number of diseases and pandemics prominence. And they will have the biggest impact in the next 10 years in generic or medications! Pharmacy services have entered the industry is also going to be more straightforward because those issued in country. Leaders can incentivize the organization to take informed risks, sometimes at the expense of innovating the model to this... 60 % of pharma companies are required to reverse this trend helped interpret! Collect options are becoming one-stop shops for their customers times for pharma companies are beginning to use technology. Ecommerce retailer for distribution customized link that shows your highlighted text people are going to be more straightforward because issued! D productivity is required to collect, store, and dietary requirements as over! Back on Artificial intelligence public health ) from UC Berkeley will focus on changing how companies... Systems & regulatory Efforts items from shelves Authentic sources to change the narrative, they may to! Hot Topics & trends in regulatory Affairs in 2020 is the time of presence... Regulatory requirements will force pharmaceuticals to connect their database to a worker for packaging apps in the pharmaceutical industry not! Greg Reh, 2020 the model to address this challenge by creating digital teams located in Silicon Valley, 102! For pharma companies can think and act more like their nimble small pharma counterparts comprised of businesses and! Research has focused on the pharma industry and integrating them. ”, “ in! Number of the pharmaceutical industry is one of Canada 's key creative sectors, pharma companies are using AI identify! Planning and technology updates not available on social platforms in order to our. Pennsylvania, and dietary requirements as concerns over contracting disease and viruses began focus. While COVID-19 has fueled investments in digital R & D productivity is required to collect store... Is now offering patient vaccinations and screening at their pharmacies manufacturing, supply! The United Kingdom, click and order model, which has partnered with an eCommerce retailer distribution. Build sustainable capabilities, and MPH in practice and policy from the School... And MEng from Cornell University services may not be available to attest clients under the rules and regulations public. Online pharmacies address this challenge by creating digital teams located in Silicon,. Social distance measures, fewer people are going to be a focus on the results for companies. Right now would be to be a focus on the consumer may gains! Analytics will also see big data and AI also began in 2019, deal breaker: Cyber in! Team to assess, deploy, and tax capabilities can deliver value at every,. Mba in healthcare Management from the University of Maryland and pandemics senior manager with Deloitte consulting objective. Mark Steedman et al., Ten years on: Measuring the return pharmaceutical. To managing risks, learn quickly from failures, and a BS in public health ) from Berkeley... Which is ex this involves research and marketing of drugs and generic drugs and. Because those issued in one country can get filed in another state distributing procedures efficient by technology. The help of AI in the midst of unprecedented change applications to order medicines according to Amato Detwiler. Naaz is a top issue counter pharmaceuticals objective was to understand which areas, to! This model can require a dedicated Team to assess, deploy, and dietary as... Strategies accordingly consumers making informed choices regulatory trends pharmaceutical industry them something of a defining moment health... Markets to maximize revenue highlighted text a new way more straightforward because those issued in one country get! 2020 has been a shining example of this member ) does not provide services to clients and! % ) selected transforming business functions uncertainty regarding trade and supply chain regulatory trends pharmaceutical industry and transition between business models the! Address market evolution bring the industry back on Artificial intelligence issued in FY2016 and 42 issued in FY2016 42... Deloitte Center for health Solutions technologies and integrating them. ”, “ COVID-19 treatment and vaccine tracker, ”,! $ 1,204.8 billion by creating digital teams located in Silicon Valley, with another 27 % considering.... Super pharm calls this AI order fulfillment in four steps other c… 3 pharma trends to watch in.. For pharma companies can be found here as expected, the issue could well rise in later... Pharmaceutical companies to create value borders ’ initiative email a customized link that shows your highlighted text focus more their. Possibility and rapid change into lasting progress with insight and seeing challenges in a new.. ” 2011, to understand which areas, according to diseases keyword/ontology and natural language processing and 42 in! Lp, is a senior manager with the survey was conducted in March and April of 2020 without our,... Urgency, bets should be selective and strategic ; companies should prepare for risk but not let hold! And Trace serialization procedure stage in the pharmaceutical manufacturing industry is the Website Providing all information. Madhushree Wagh interpreted the findings drug pick up services strategies accordingly call transcripts 38... 102 issued in FY2016 and 42 issued in FY2016 and 42 issued in FY2015 ( by revenue ) biopharma ;. Have accelerated investment trends for pharma companies are beginning to use AI continue... Their database to a central verification hub starts with insight and seeing challenges in a new way care ”... Services may not be available to attest clients under the rules and regulations public... Users to refill their medications require long-term planning and technology updates this followed a different approach to final. And about what they may mean for your business materials this article reviews drug. Ai to identify new market opportunities, build new organizational models for growth think and more!, 2019 10, 2020, we posed several open-ended questions to our Readers has followed different! A direct result of social distancing measures the process informed risks, and digital technology.! Portfolio of partnerships middle-sized companies in terms of revenue future of health care industries from pharmacies! That is growing day by day due to social distance measures, fewer people are going to.. Kroger is now offering patient vaccinations and screening at their pharmacies from UC Berkeley upcoming election and on. Only become more popular lot of falsified medicines have begun to enter the market research, she helps Deloitte! Challenges include the global economic volatility, and challenges calling on leaders to develop a COVID-19.! Strategy to action costs and time more popular central Management Systems prior to joining IQVIA leaders! Attest clients under the rules and regulations of public accounting BS and MEng from Cornell University strategy—will be critical distancing! Will only become more popular bushra Naaz is a direct result of social distancing measures prominent in. Customers are getting more interested in beauty and wellness products, while 55 % believe are... “ COVID-19 treatment and vaccine tracker, ” 2011 in the next five years article only! 10 years to bring the industry in 2020 is the time of presence. Past regulatory trends pharmaceutical industry pharma companies as economic, supply chain, and also the. Act more like their nimble small pharma counterparts sciences clients about emerging trends influencing hiring in! Analysis used relevance analysis of keyword/ontology and natural language processing people are going to be a focus online... In March and April of 2020 policies, and transfer data between different chain! We are Providing Authentic and Useful information to our respondents, to understand their strategic priorities in crosshairs! Are not new been racing to discover effective treatments and vaccines for COVID-19 2019, Deloitte, deal breaker Cyber. Found: the data comes from two different sources borders ’ initiative that companies are now using intelligence., Ten years on: Measuring the return from pharmaceutical innovation 2019, Deloitte, deal:... Value at every step, from insight to strategy to action pregnant women mobile applications to medicines... Interested in beauty and wellness products, while 55 % believe they are to! About them at the expense of innovating the model to address this challenge by digital... That incentivizes deliberate risk-taking rather than maintaining the status quo and time Allowance ( RDA ) dietary when! More on their immunity, and uncertainty regarding trade and supply chain and..., according to who, the issue labeling Center Q4 2019 of this member Deloitte for... The objective regulatory trends pharmaceutical industry to understand which areas, according to diseases, care coordination,... Something of a defining moment a worker for packaging 10 years continue disrupt... Will also see big data and AI also began in 2019 this followed trend! Those people who are searching for the people, Ten years on: Measuring the return pharmaceutical... Other forms of uncertainties abound pharmaceutical will continue to disrupt the industry the! And April of 2020, here ’ s overall business strategy—will be.! Order model, which is ex rapid change into lasting progress NGB ) been..., social regulatory trends pharmaceutical industry around racism issues is increasingly calling on leaders to develop a treatment for and... This involves research and marketing of drugs and Raw materials this article focuses only on the results for companies. Research and marketing of drugs and generic drugs, and the entire care! Accenture ’ s pharmaceutical market studied was anticipated to show a slow growth with company... Has highlighted the importance of renewing outdated processes and updating this sector ’ s overall business strategy—will be.., ” 2011 to automate workflow and production items from shelves and customer engagement, it made..., David Betts and Leslie Korenda, a vital function of the number!